Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
44,022,105
-
Share change
-
+1,761,047
-
Total reported value
-
$869,193,186
-
Price per share
-
$19.75
-
Number of holders
-
73
-
Value change
-
+$26,485,491
-
Number of buys
-
46
-
Number of sells
-
31
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q1 2021
As of 31 Mar 2021 Vaxcyte, Inc. - COMMON STOCK (PCVX) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,022,105 shares of stock of the company.
Largest 10 holders included FMR LLC, TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, Abingworth LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, BlackRock Inc., Medicxi Ventures Management (Jersey) Ltd, and STATE STREET CORP.
This table shows 73 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.